Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Couch

Showing results (391-400 of 697) with videos related to

Pageof 70
Sort By:
NPJ Breast Cancer|October 24, 2025
CHFR expression and sensitivity of breast cancer cells to antimitotic agents in vitro and in the I-SPY trialAndrea E Wahner Hendrickson, Karen S Flatten, Taylor M Weiskittel, et al.
Breast Cancer Research and Treatment|December 19, 2023
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCYJudith Balmaña, Peter A Fasching, Fergus J Couch, et al.
JCO Precision Oncology|August 25, 2020
Pathogenic Variants in Cancer Predisposition Genes and Prostate Cancer Risk in Men of African AncestryMarco Matejcic, Yesha Patel, Jenna Lilyquist, et al.
Human Mutation|December 16, 2020
Whole-exome sequencing of non-BRCA1/BRCA2 mutation carrier cases at high-risk for hereditary breast/ovarian cancerPaula S Felicio, Rebeca S Grasel, Natalia Campacci, et al.
Nature|January 8, 2025
Functional evaluation and clinical classification of BRCA2 variantsHuaizhi Huang, Chunling Hu, Jie Na, et al.
Journal of Medical Genetics|June 1, 2005
Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variantsP K Lovelock, S Healey, W Au, et al.
Journal for Immunotherapy of Cancer|June 3, 2026
Spatially resolved single-cell landscape of tumor immunotypes reveals the central role of interferon signaling and plasmacytoid dendritic cells in triple-negative breast cancerYi Liu, Jodi M Carter, Yaohua Ma, et al.
JAMA Oncology|February 29, 2024
MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence VariationsJan Lubinski, Joanne Kotsopoulos, Pal Moller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2025
Germline-Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking ATM to TP53 Synthetic EssentialityAli T Arafa, Siddhartha Yadav, Catherine H Marshall, et al.
NPJ Breast Cancer|November 10, 2017
Erratum: Author Correction: The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer riskThomas P Slavin, Kara N Maxwell, Jenna Lilyquist, et al.
Pageof 70

Showing results (391-400 of 697) with videos related to

Sort By:
Pageof 70
NPJ Breast Cancer|October 24, 2025
CHFR expression and sensitivity of breast cancer cells to antimitotic agents in vitro and in the I-SPY trialAndrea E Wahner Hendrickson, Karen S Flatten, Taylor M Weiskittel, et al.
Breast Cancer Research and Treatment|December 19, 2023
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCYJudith Balmaña, Peter A Fasching, Fergus J Couch, et al.
JCO Precision Oncology|August 25, 2020
Pathogenic Variants in Cancer Predisposition Genes and Prostate Cancer Risk in Men of African AncestryMarco Matejcic, Yesha Patel, Jenna Lilyquist, et al.
Human Mutation|December 16, 2020
Whole-exome sequencing of non-BRCA1/BRCA2 mutation carrier cases at high-risk for hereditary breast/ovarian cancerPaula S Felicio, Rebeca S Grasel, Natalia Campacci, et al.
Nature|January 8, 2025
Functional evaluation and clinical classification of BRCA2 variantsHuaizhi Huang, Chunling Hu, Jie Na, et al.
Journal of Medical Genetics|June 1, 2005
Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variantsP K Lovelock, S Healey, W Au, et al.
Journal for Immunotherapy of Cancer|June 3, 2026
Spatially resolved single-cell landscape of tumor immunotypes reveals the central role of interferon signaling and plasmacytoid dendritic cells in triple-negative breast cancerYi Liu, Jodi M Carter, Yaohua Ma, et al.
JAMA Oncology|February 29, 2024
MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence VariationsJan Lubinski, Joanne Kotsopoulos, Pal Moller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2025
Germline-Somatic Interactions in BRCA-Associated Cancers: Unique Molecular Profiles and Clinical Outcomes Linking ATM to TP53 Synthetic EssentialityAli T Arafa, Siddhartha Yadav, Catherine H Marshall, et al.
NPJ Breast Cancer|November 10, 2017
Erratum: Author Correction: The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer riskThomas P Slavin, Kara N Maxwell, Jenna Lilyquist, et al.
Pageof 70